PFE - What's Going On With Novavax Stock? | Benzinga
Novavax, Inc. (NASDAQ:NVAX) shares are trading higher Wednesday, and the stock is up by more than 300% over the past month. Here's a look at what's going on.
What To Know:
Novavax shares have gained nearly 40% over the past five days, boosted by COVID-19 headlines.
Vaccine makers reported data from animal studies Wednesday showing shots targeting the JN.1 variant that was dominant earlier this year could neutralize newer subvarients such as KP.2 more effectively than the older shots.
Pfizer, Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) will be ready to supply the updated vaccines immediately upon approval, while Moderna, Inc. (NASDAQ:MRNA) and Novavax project delivery in August.
Related News: Wedbush’s Dan Ives Says WWDC 2024 Is ‘Most Important Event For Apple In Over ...